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Abstract
The  silicon-based  integrated  microarray  biochip  (IMB)  is  an  inter-disciplinary
research  direction  of  microelectronics  and  biological  science.  It  has  caught  the
attention of both industry and academia, in applications such as deoxyribonucle‐
ic acid (DNA) and immunological detection, medical inspection and point-of-care
(PoC)  diagnosis,  as  well  as  food  safety  and  environmental  surveillance.  Future
biodetection  strategies  demand  biochips  with  high  sensitivity,  miniaturization,
integration, parallel, multi-target and even intelligence capabilities. In this chapter,
a  comprehensive  investigation  of  current  research  on  state-of-the-art  silicon-
based integrated microarray biochips is presented. These include the electrochem‐
ical  biochip,  magnetic  tunnelling  junction  (MTJ)  based  biochip,  giant
magnetoresistance  (GMR)  biochip  and  integrated  oscillator-based  biochip.  The
principles, methodologies and challenges of the aforementioned biochips will also
be discussed and compared from all aspects, e.g., sensitivity, fabrication complex‐
ity  and  cost,  compatibility  with  silicon-based  complementary  metal-oxide-
semiconductor  (CMOS)  technology,  multi-target  detection  capabilities,  signal
processing  and  system integrations,  etc.  In  this  way,  we  discuss  future  silicon-
based fully integrated biochips, which could be used for portable medical detection
and low cost PoC diagnosis applications.
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1. Introduction
Silicon-based  integrated  microarray  biochips  (IMB)  are  an  inter-disciplinary  research
direction of microelectronics and biological science. They have caught the attention of both
industry and academia, in applications such as deoxyribonucleic acid (DNA) and immuno‐
logical  detection,  medical  inspection  and  point-of-care  (PoC)  diagnosis,  as  well  as  food
safety and environmental surveillance. Future biodetection strategies demand biochips with
high  sensitivity,  miniaturization,  integration,  parallel,  multi-target  and  even  intelligence
capabilities [1, 2]. Recent studies focus on the high sensitivity and multi-target microarray
biochips for accurate and early disease diagnosis. They also discuss treatment that is based
on silicon compatible technologies due to its low cost, large-scale and readily integration
with signal extraction and processing front-end and back-end circuits monolithically for a
lab-on-a-chip solution [3-16].  Such studies oppose conventional assays that are currently
used in hospitals and laboratories, e.g., enzyme-linked immunosorbent assay (ELISA) [17]
and fluorescent detections [18], etc.
Biosensor microarray assays are one type of popular method to perform comparable biological
detections. These are typically carried out for the analysis of large-scale gene and protein
expression changes in a biological sample. Although there are many different forms of
microarray biochips, they can be generally classified into two categories, based on the sensing
methodologies: labelled and label-free. Labelled techniques tag an analyte of interest with an
externally observable label such as a magnetic tag [9-16] or fluorophore [18]. On the other hand,
label-free techniques detect an intrinsic property of the biomolecule such as the electrochemical
charge/current [3-8], mass, thermal reactivity, etc. One typical example of label-free detection
is electrochemical microarray, which senses the current induced in the binding reaction during
detection. Meanwhile, magnetically labelled assays with ultra-high sensitivity, such as GMR
and MTJ microarrays, are labelled techniques.
Recent studies of IMB focus on high sensitivity and multi-target microarray biochips, based
on silicon compatible technologies. For example, CMOS, due to its low cost, large-scale and
readily integration with signal extraction and processing front-end and back-end circuits
monolithically for a lab-on-a-chip solution. State-of-the-art silicon-based IMB assays include
the electrochemical microarray biochip [3-8], GMR and MTJ microarray biochips [9-14] and
the fully CMOS compatible oscillator microarray biochip [15-17].
This chapter is organized as follows. Section 2 presents the electrochemical microarray biochip
and illustrates examples of state-of-the-art electrochemical microarray biochips. Furthermore,
design issues and considerations are elaborately analysed and discussed. Section 3 discusses
magnetically labelled detection assay that are based on GMR and MTJ sensors and biochips.
Methodology, trade-offs and calibration strategies are also presented, as well as a system
prototype with performance evaluations and comparisons. Section 4 discusses biochip assay
based on on-chip oscillator microarray that is fully compatible with modern aggressively
scaled CMOS technology, with a proposed in-situ calibration strategy. Finally, the chapter
concludes in Section 5, where future directions for IMB research are envisioned and reviewed.
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2. Electrochemical microarray biochips
An electrochemical microarray biochip is one type of sensor used for DNA and protein
detection. It has caught the attention of both academia and industry due to its applications in
DNA and immunological analysis, analyte detection, drug delivery, trends of miniaturization
and large-scale integration with CMOS technology for a system-on-a-chip (SoC) solution. In
this strategy, the target detection and hybridization action are converted into electric current
signals on the microarray electrodes on the chip surface. This is readily extracted by the high
sensitivity analogue circuit front-end of the CMOS biochip. The integrated circuit (IC)
interfacing, which is composed of an analogue circuit front-end for signal extraction, multi‐
plexor (mux) and demultiplexor (demux) circuits for electrode enabling and decoding, as well
as a potentiostat for electrode voltage stabilization, governs the overall performance of the
microarray biochip.
2.1. Design challenges and considerations
Along with the development of micro- and nano-fabrication technologies, such as lithograph,
nano-imprint, electron beam, etc., the feature size of recent electrode microarray tends to shrink
towards a nanometre scale, together with the scaling down of CMOS technology. However,
electrodes of nanoscale seriously suffer from background noise and random currents in a
biochemical sample solution medium. This degrades the sensitivity and makes the design of
IC interfacing difficult. Previous research suggests that the minimal sensitivity of signal
extraction front-end IC should be at least at the order of pico-ampere (pA, 10-12 A) or lower.
Moreover, for an effective current monitoring and response, the bandwidth must be several
MHz or higher - an even more difficult task. Prior applications of interfacing IC, based on
potentiostat [19], trans-impedance amplifier [20] and current amplifier [21, 22] have been
reported.
Large-scale integration also presents challenges regarding the signal processing back-end. For
example, there are at least 20 known amino acids, while there are over 500 types of haemo‐
globin in human blood. A large amount of data has to be extracted and analysed by the back-
end circuitry during a single detection phase. This heavily burdens the digital signal processor
(DSP) or field-programmable gate array (FPGA). Recent research on neuromorphic circuits
and systems, based on memristive devices and circuit, may provide a novel pathway for the
large-scale, parallel signal processing and mode recognition in the near future.
The scaling down of electrode microarray is also a challenging task. Investigators have
proposed a post-CMOS fabrication methodology [8]. However, when shrinking the device
sizes, this methodology suffers from keyhole issues, resulting in the deterioration of the surface
roughness and eventually, the sensitivity. Therefore, a co-design and fabrication regarding the
microarray floor planning, lithography and etching are currently under investigation.
2.2. Current research
In previous studies, the electrochemical detection and sensing of DNA has been reported [3].
Here, the viability of the methodology has been verified. The first fully CMOS integrated DNA
microarray biochip was published by Infineon. In this case, a 128-spot electrode structure with
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in-pixel analogue-to-digital conversion was realized, achieving 100 dB of a dynamic range for
direct current (DC) detection [4]. The chip was improved to a sub-nanoampere level [5] by
introducing differential architecture. However, limited by the in-pixel integrator, the scale of
single electrode could not be reduced beyond 100 µm. This prevented the downscaling of the
electrode feature size and the upscaling of the microarray’s integration level. A fluorescent-
based biosensor microarray was introduced [6], which utilized the in-pixel photo-diode. This
was followed by a preamplifier and analogue-to-digital converter (ADC), which were used to
detect the fluorescence on the target. A 10−12A level current sensitivity and a detection limit of
0.5 nM were achieved. Although a microarray is extremely sensitive in DC detection, it can
hardly respond to transient signals with a bandwidth of 1 kHz and above. This is mandatory
in broadband sensing (10 kHz and above) and low noise alternating current (AC) detections.
In this section, we present a fully integrated 64-pixel CMOS biosensor microarray, which
is  based on  memory addressing  architecture.  Thanks  to  the  pixel-decoding  scheme,  the
embedded potentiostat operational amplifier (opamp) and current amplifiers are shared by
all  of  the  pixels  in  the  microarray.  This  helps  to  reduce  the  pixel  complexity  and pro‐
vides a  pathway to the miniaturization of  electrodes towards a  nanoscale.  An electrode
feature size of 600 nm has been successfully demonstrated. To the best of our knowledge,
this is the smallest size among published works. Moreover, the embedded current amplifi‐
er is realized with pico-ampere sensitivity in order to reconcile with the current level of
the nanoscale electrodes. This is over 15 kHz bandwidth, which supports both the high-
speed sensing and low noise AC detections [7, 21].
The system architecture of the proposed biosensor microarray is shown in Figure 1. It is
designed with a 64-pixel of 8 × 8 working electrode microarray, together with interdigital
references and counter electrodes. A two-stage address decoding approach (pre-decoding and
pixel-decoding) is introduced to selectively activate the microarray’s working electrodes. An
on-chip potentiostat opamp P is implemented to stably control the electrode potential and
provide electrochemical current to the electrolyte from a negative feedback mechanism during
biosensing detections. Meanwhile, an ultra-low-current amplifier (ULCA) is also integrated in
order to sense the detection current and introduce amplification, before being sent out to off-
chip devices. The proposed ULCA achieved a gain of 20 dB, a bandwidth of 15.5 kHz and a
current sensitivity of less than 38 pA [21]. The potentiostat serving for stabilizations of
electrolyte potential and accommodation of electrochemical current is realized by an opamp
with a rail-to-rail input common-mode range and Class-AB output stage. The proposed
biosensor microarray is realized in standard 0.18 µm CMOS technology. Figure 2(a) shows the
die micrograph of the chip, which occupies 2 mm by 2 mm of the chip area. The top electrodes
of the microarray are fabricated following the procedures in previous studies [8]. Limited by
the etching resolution, the minimal electrode feature size demonstrated was 600 nm, which is
the smallest among published works. A biosensor detection system, based on magnetic nano-
particle (MNP), biotinlated polystyrene and streptavidin, is utilized to demonstrate the
functionalities of the proposed microarray. The fluorescent results are shown in Figure 2(b)
and zoomed in by Figure 2(c) and (d). The normalized fluorescent intensities are measured as
127 and 136, while the noise background is 12.3. The translating to signal-to-noise ratio (SNR)
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is 10.1 dB and 10.4 dB, respectively. The measured currents start from 1∼2 µA and gradually
reduce in the first 20 seconds, due to the electric shielding effect of the targets. They eventually
saturate at about 20 nA and 7.3 nA, respectively.
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Figure 1. (a): Circuit architecture of proposed biosensor microarray.
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Figure 2. (a): Addressed working electrodes on the microarray, (b) fluorescent detection results on the addressed elec‐
trodes, (c) zoom in on the 8 µm square electrode and (d) zoom in on the 600 nm spiral electrode.
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2.3. Discussions
Electrochemical microarray biochips are one type of widely interested assay that are capable
of mid-sensitivity multi-target detection. They have important applications in multi-target
DNA and immunological analysis, as well as in analyte detection and drug delivery. Along
with the trends of miniaturization and large-scale integration with CMOS technology for a
SoC solution, various issues need to be solved in future research. Such issues include back‐
ground noise and random currents in a biochemical sample solution medium during the
shrinking of electrode feature size, post-CMOS fabrication technologies, parallel back-end
signal processing and mode recognition. The current sensitivity of recent reported applications
falls in the nano-ampere range, which is limited by background noise and random currents in
the biochemical medium and buffer. This prevents its application for higher sensitivity sensing
and detection applications.
3. GMR and MTJ microarray biochips
In recent years, rapid biological detection based on GMR and MTJ sensors and biochips is a
hot issue. This is due to its interesting features such as being fast, cheap, user-friendly and
acceptable high sensitivity [9-14]. As there is less magnetic material in body fluid, the magnetic
signal detected by GMR and MTJ biosensors suffers minimally from the interferences of body
fluid and therefore, exhibits a high sensitivity.
3.1. Overview
The GMR and MTJ biosensor detection system generally consists of several steps. These
include the biochemical reaction on the surface of the sensor, analyte tagging by super-para-
magnetic nano-particles, receiving signals from the top of the sensor, small signal extraction
circuit front-end, digital domain data processing and correction back-end. These are shown in
Figure 3 and Figure 4.
Figure 3 and Figure 4 show the detailed detection scheme and signal processing steps. Firstly,
probe molecules that target multiple specific analytes are immobilized on the biosensor chip
surface through biochemical bonding and/or reactions. During the detection phase, the analyte
molecules are introduced, which are specifically captured by probes that are readily immobi‐
lized on the sensor surface. In the labelling phase, a labelling molecule tagging with MNP is
subsequently bonded with analyte molecules, which are captured by probes in the detection
phase. The analytes, acting as a bridge between the probe molecule and the MNP label, are
therefore fixed on the surface of the biosensor chip. Finally, MNPs and analytes that are not
fixed on the top of the sensor surface are washed away. The number/density of MNPs
immobilized on the biosensor surface is proportional to the analyte concentration to be
detected. The probe and analyte in the aforementioned detection assay can either be DNA or
antigen/antibody protein, depending on the applications.
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Figure 3. Biochemical detections paradigms based on MNP-labelled targets.
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Figure 4. Signal flow and processing steps of GMR and MTJ biosensor detection system.
3.2. MTJ microarray biochips
Recent progress on the MTJ biosensor multi-target microarray biochip has been reported [9].
In such studies, a fully automated in vitro diagnostic (IVD) system for diagnosing acute
myocardial infarction was developed. This uses high sensitivity MTJ array as sensors and 300
nm nano-magnetic particles as tags. An array of 12 × 106 MTJ devices are integrated with a
three metal layer CMOS circuit. Consequently, 48 different types of bio targets can be analysed
simultaneously. A micro-fluidic cartridge, which contains all of the reagents necessary for
completing the assaying process, is also assembled. Electrical, mechanical and micro-fluidic
pumping devices are also integrated. The system yields results of the three major acute
myocardial infarction (AMI) biomarkers (cTnI, MYO, CK-MB) in 15 minutes. An extremely
high sensitivity of 0.1 ng/ml is realized and the dynamic range of detention is over three orders.
However, system solutions that are based on MTJ microarray biochips are pricy in terms of
the MTJ sensor itself and the circuit board/microfluidic channel integration. Meanwhile, over
100 wiring connections have to be realized and therefore lowering the yield. In the present
form, this can hardly be commercialized.
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3.3. GMR microarray biochips
GMR biosensors and biochips are proposed and utilized in the above detection assay for their
acceptable high sensitivity responses to MNP labels, as well as their lower fabrication cost,
compared with MTJ microarray biochips. This makes them potentially suitable for mass
production and commercialization. Recent progress has been reported by researchers in
Stanford [10]. In their study, 256 separate GMR sensors were fabricated and a CMOS signal
extraction front-end with 16 channel ΣΔ modulators was designed and realized in 180 nm
CMOS process. This has a sensitivity of around 10 picomolar (pM), roughly equivalent to about
50 ppm of GMR resistance change. However, a number of issues remain unsolved. Firstly,
temperature calibrations must be performed during the detection phase in order to cancel out
the local temperature variation effects around the GMR sensor detection region. The calibra‐
tion is made with one single fixed temperature coefficient over a wide range of GMR sensors.
This incurs inaccurate results. Secondly, the biochemical buffer solution on the detection region
is manually controlled on a disposable test stick. This can hardly be extended for multi-target
applications with 10 or more samples and thus, is impractical with regard to efficiently
controlling the biochemical reactions on multiple targets.
In this section, a complete prototype of GMR microarray biochips and system is presented.
The GMR biochip, signal extraction IC, back-end signal processing, microfluidic channels,
novel calibration strategies and mechanical parts with microfluidic channels are all integrated.
The system performance shows a sub-50 ppm sensitivity, corresponding to roughly two 500
nm MNPs within a 1000 µm2 GMR sensor detection area on average. This advances the present
application [11].
The physical structures of the GMR biosensor are illustrated in Figure 5.
The GMR biosensor is a multilayer structure device. It has two major functionality layers: a
pinned layer and a free layer. The pinned layer is a layer with fixed magnetic moment direction.
Meanwhile, the free layer features a changeable magnetic moment direction, which can be
modulated by an externally applied magnetic field. Both of the layers are ferromagnetic and
are separated by a non-ferromagnetic layer in between them.
A GMR sensor is generally designed with two alternative structures, as shown in Figure 5. In
the left subfigure, the electrons flow vertically through both the pinned and free layer (Current
Perpendicular to Plane, CPP). The electrons experience scattering in ferromagnetic layers,
depending on the magnetic moment of the layer and the electron spin. When the pinned and
free layers exhibit parallel magnetic moment direction, the electrons experience the lowest
scattering through both layers, corresponding to the lowest resistance state. If the magnetic
moment directions of the pinned and free layer are antiparallel, electrons experience large
scattering though both layers. This results in the highest resistance state. In the right subfigure,
the electrons flow horizontally (Current In Plane, CIP). The physics of CIP is similar to the CPP
structure. Furthermore, the sensor exhibits different resistances when the magnetic moment
direction of the free layer is modulated by the external magnetic field. As the length of the
GMR sensor is far larger than the thickness, the CPP structure normally has a higher magneto-
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resistance (MR) than its CIP counterpart. However, it is hard to fabricate and not easily
integrated with the planar process. Modern GMR biosensors are generally fabricated with a
CIP structure.
Super-paramagnetism MNP is utilized. This can be magnetized by the applied magnetic field
and produce a small magnetic field around the MNPs, modulating the resistance of the sensor.
Firstly, a DC biasing magnetic field is applied to the sensor. This magnetic field magnetizes
the MNPs on top of the sensor and forces them to produce small magnetic fields in the same
direction, with the applied magnetic field on top of the sensor. An extra AC magnetic field is
further applied in order to modulate the magnetic field of the MNP and consequently, induce
the resistance change of the sensor itself at the same frequency.
To readout the change of the resistance of GMR sensor, a voltage is applied to the sensor. The
output current flowing through the sensor is measured and readout. Considering that the
flicker noise is large at a low frequency and that the resistance change caused by the MNPs is
only several tens ppm of the initial resistance (chosen as a few kΩ) of the sensor, an AC voltage
running at several kHz, together with an AC magnetic field at a few hundred Hz, is utilized
to read out the signal. Therefore, the output current through the sensor can be calculated by
the following formula:
( )
( ) ( ) ( )( ) ( )( )cGMR c c s c ss
Vcos f t V V RI f t f f t f f tRR Rcos f t R200 0
2 cos 2 (cos 2 cos 22 2
p p p pp
D= = - + + -+ D (1)
where V is the amplitude of the applied voltage, R0 is the initial resistance of the sensor, ΔR is
the resistance change of the sensor due to the applied magnetic field, MNPs, fc is the frequency
of the external AC voltage and fs is the frequency of the AC magnetic field.
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Lead
Lead
Free Layer
Non-Ferromagnetic Layer
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Lead Lead
Figure 5. GMR biosensor structures.
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Figure 6. Signal processing flow of the proposed GMR sensing system, including the main tone cancellation, amplifica‐
tion, filtering, ADC, FFT and output correction.
It can be seen from Figure 6 that the sensor acts as a mixer and produces three tones at fc, fc+fs
and fc-fs. As ΔR is much smaller than R0, the main tone amplitude at fc is higher than the side
tones amplitudes at fc+fs and fc-fs, which are signals of interest, since the effects of MNPs only
relate to ΔR.
The MR of a GMR sensor is generally less than 15 %. The operation point is chosen at the middle
point with maximal slope and the ΔR is generally about 1~3 % of R0. Meanwhile, the resistance
change due to MNPs can be as small as 0.1 % of ΔR. The signal is very small compared to the
centre tone, requiring an ADC with a dynamic range of over 100 dB - an extremely difficult
number to achieve. To overcome this issue, cancellation of the main tone is necessary. This can
be implemented by applying an AC voltage with the opposite phase to a reference resistor of
the same resistance as the GMR sensor. The centre tone can be reduced by at least 20 dB,
considering a 10 % deviation between the resistance of the GMR sensor and the cancellation
resistor.
After cancellation, a filter is introduced to suppress the noise out of the band. It is followed by
an amplifier before ADC in order to transform the signal from an analogue to digital domain.
In the digital domain, Fast Fourier Transform (FFT) is used to calculate the frequency spectrum
and eventually extract the signal from the side tones.
The signal can be extracted by the following formulas:
ST
CT ST
4MR 2= - (2)
( )
max
MR t MR
MR
(0)Signal  -= (3)
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where CT is the centre tone or main tone of the GMR signal before cancellation, ST is the side
tone. The centre tone amplitude before cancellation can be easily recovered based on the gain,
cancelling resistance and source amplitude:
s
before cancellation after cancellation
c
VRCT CTR   - -= ± (4)
with the sign decided by the resistances of the GMR sensor and the cancellation resistor.
As the sensor resistances are sensitive to the environment, output correction and calibrations
of temperature variations are always necessary in order to ensure the veracity of the detection.
Therefore, the temperature-calibrated scheme is proposed in this section.
Firstly, considering the temperature variations of the initial resistance of the GMR sensor and
the resistance change caused by the magnetic field and MNPs, the GMR current can be written
as,
( )
( )cGMR s
Vcos f tI R T R T cos f t0
2
(1 ) (1 ) 2
p
a b p= + D + D + D (5)
where α is the temperature coefficient of the initial resistance of GMR sensor and β is the
coefficient factor of the resistance change due to MNPs. It follows that
( ) ( ) ( )( ) ( )GMR c c s c s
V V R TI f t f f t f f tR T R T2 20 0
1 1cos 2 cos 2 ( ) cos 2 ( )1 2 1
bp p pa a
æ öæ ö D + Dç ÷» - + + -ç ÷ ç ÷+ Dè ø + Dè ø
(6)
Then, the CT and ST can be calculated by:
( ) ( )
( ) ( ) ( )( ) ( )( )
V V T TR T R
V R T V R V RT T TR R RT
T T
0 0
2 2 2 2
0 0 0
1CT t 1     ( 1)1
1ST t 1 1 2 1 22 2 21
( 1, 1)
a ba
b b a b aa
a b
æ ö= » - D Dç ÷+ Dè ø
æ öD + D D Dç ÷= » + D - D » + - Dç ÷+ Dè ø
D D
=
= =
(7)
In normalizing the CT and ST to them at initial time 0, we have,
( )
( )
CT t TCT
ST t TST
( ) 1(0)
( ) 1 2(0)
a
b a
= - D
= + - D
(8)
Silicon-based Integrated Microarray Biochips for Biosensing and Biodetection Applications
http://dx.doi.org/10.5772/60441
119
We can define κ as the following relationship between CT and ST,
( )
( )
( )
( )
ST t
ST
CT t
CT
10 2
10
b ak a
æ ö-ç ÷ç ÷ -è ø= = -æ ö-ç ÷ç ÷è ø
(9)
One can obtain κ by linear fitting and utilizing the centre tone to calibrate the side tone,
( )
( )
( )
( ) ( )( ) ( )
TCT t
CT
V R V RT TR R2 20 0
1 1CF 1 21 10
1ST ST t CF 1 2 1 22 2
b ak
b a b a
= =æ ö + - D+ -ç ÷ç ÷è ø
D D= ´ » + - D ´ =+ - D
(10)
From the above equation, the temperature variation can be easily calibrated out during the
detection. The major improvement is that the data obtained at the beginning of the test are
utilized to calculate the temperature coefficient κ for every single sensor instead of using a
standard number. Consequently, this produces a better correction and more accurately reduces
the temperature effect over the whole chip.
A complete circuit and system solution prototype, including the GMR biosensor design and
fabrication, small signal extraction front-end, data conversion and signal processing back-end
for the GMR biosensing and detection assay, has been proposed and realized by the experi‐
ment.
The proposed GMR biosensor is a NiFe/CoFe/Cu/CoFe/PtMn multilayer structure, as shown
in Figure 7(a). A 40 nm thick SiO2 layer is fabricated on top of the multilayer sensor in order
to keep it from oxidization and prevent electrical shorting. Furthermore, a thinner passivation
layer achieves closer proximity between the magnetic particle and sensor surface for higher
sensitivity, resulting in an easier electric broken down.
A biosensor chip containing 12 separate GMR sensors was fabricated, as shown in Figure
7(b). Taking into consideration the trade-off between the statistical fluctuation of magnetic
particle distributions and uneven magnetic field effect during detection, the physical size of
each sensor is 120 µm × 120 µm.
In the system prototype, the signal extraction front-end with main tone cancellation, amplifi‐
cation and filtering functions has been realized by CMOS ICs. The sampling frequency of the
ADC is 1 MHz and each packet of data contains a signal of six seconds. First, the data is divided
into 60 pieces and each piece is sent to a Hanning Window for data smoothing before FFT. An
average of over 10 groups of data is used to reduce the noise. An adaptive filter algorithm is
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used to further reduce the noise and a 50 % noise reduction can be achieved. To further improve
the sensitivity of the sensing system, the proposed temperature calibration scheme is also
introduced and realized.
Figure 7. (a): Multilayer structure of the proposed GMR sensor and (b) the GMR biosensor chip containing 12 sensors.
Figure 8(a) shows the α prototype detector utilizing the GMR biosensor detection scheme that
is proposed in this section. The structure of the detector is shown in Figure 8(b), including the
front-end circuit board, signal processing DSP, PC interface and mechanical parts of the
disposable microfluidic box.
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Figure 8. (a): α prototype detector system, utilizing the proposed GMR biosensor detection scheme and microarray bi‐
ochip and (b) structure of the α prototype detector.
Silicon-based Integrated Microarray Biochips for Biosensing and Biodetection Applications
http://dx.doi.org/10.5772/60441
121
Figure 9. Magnetic signal versus the number of magnetic particles. Each magnetic particle produces a signal of about 2
ppm.
In the experiment, magnetic particles with diameters of 500 nm are utilized to produce the
target magnetic signal. The current leakage between the two connection wires can introduce
a signal as large as several hundred ppm. As a result, the data has to be collected when the
surface is dry. A microscope is used to observe and count the magnetic particles on top of the
sensor. The relationship between the number of magnetic particles and the output signal is
shown in Figure 9. It can be seen that a sensitivity of sub-50 ppm has been achieved in the
proposed system. In this case, about 30 magnetic particles on a 120 µm × 120 µm sensor surface
are observed. Therefore, on average, each magnetic particle roughly produces a signal of about
2 ppm. Table 1 shows comparisons with other GMR biosensing systems. This work achieves
superior performance versus prior arts. In summary, biological detections based on the
proposed GMR biochips and system have been verified by experiments and a sub-50 ppm
sensitivity has been reached, advancing the present work.
Sensor Size
(μm × μm)
MNP Diameter (nm) Min. Detectable Num.
N
N per 1000 μm2 Area
[10] 100 × 100 50 2000 200
[12] 120 × 67.5 30 N/A N/A
[13] 160 × 58.5 1000 N/A N/A
[14] 1500 300 3 (theoretical) 2
This Work 120 × 120 500 30 2.08
Table 1. Comparisons with state-of-the-art GMR biosensing systems.
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3.4. Discussions
Magneto-sensitive detection assays are proved with extremely high sensitivities and provide
full support to multi-target (~100 targets) biochemical analysis applications, e.g., DNA and
immunological detections that are widely used in laboratories and hospitals. Biosensing
systems and chips based on MTJ and GMR microarrays are possible candidates. Previous
research suggests that a MTJ microarray biochip has a pricy sensor with unsatisfied yield.
Thus, in the present form, it can hardly be commercialized. On the other hand, a GMR
microarray biochip features a sub-50 ppm high sensitivity response to MNP labels and a lower
fabrication cost compared to a MTJ microarray biochip. This makes it potentially suitable for
mass production and commercialization in the near future. However, both biochips require
an extra fabrication flow beyond the CMOS process, preventing the monolithic integration
with acquisition IC front-end, signal processing back-end and DSP for a SoC solution to further
improve system performance and reduce costs.
4. Oscillator-based microarray biochips
In the area of medical diagnosis, high accuracy, fast speed and low cost biosensor systems are
always in demand. However, conventional biosensor systems, such as fluorescent labelled
biosensor and MTJ and GMR biosensors, require complicated extra-process steps or fabrica‐
tions. These are not fully compatible with CMOS technology and, consequently, the cost and
design complexity can hardly be reduced. Moreover, both MTJ and GMR sensors require
external biasing magnetic field, which complicates implementing the system.
4.1. Overview
An oscillator-based microarray biochip, which relies on the frequency-shift of LC oscillators,
is one type of scheme that is potentially capable of solving these problems [15-17]. It uses an
electromagnetic mechanism to detect the changes of output frequency, which directly corre‐
sponds to the number of targets tagged by MNPs. It potentially features high sensitivity, low
cost, multi-target and easy integration, compared to GMR and MTJ biosensing strategies.
An LC oscillator is a basic component for local oscillation (LO) generation in radio-frequency
(RF) integrated circuits [23]. An inductor and a fixed capacitor oscillate at a free running
frequency f0, driven by a negative resistance from a cross-coupled transistor pair. We suppose
that some probe molecules are deposited on the inductor surface. During the detection phase,
some target molecules with MNPs labels are also deposited on the inductor and bonded with
the probes. Therefore, the MNPs change the magnetic field around the detection region defined
by the inductor, effectively changing the inductance L0 to L0+ΔL. This eventually shifts the
oscillation frequency f0, as shown in Eq. (11), where M is the target concentration and α is a
factor.
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The frequency shift Δf is proportional to the inductance change ΔL and therefore, reflects the
target molecule concentration in a sample solution.
The principle of the oscillator-based high sensitivity multi-target biochip detection is illustrat‐
ed in Figure 10. Firstly, the CMOS biochip surface with multiple detection regions is treated
by various probe molecules, which are a target of interest for probe immobilization, as shown
in Figure 10(a) and (b). During the detection phase, the sample solutions with target molecules
labelled with MNPs are brought to the detection region by either droplet or microfluidic
channel for chemical bonding and hybridization. The chip is then rinsed by DI water for surface
cleaning in order to remove non-specific bonding or contaminations. Eventually, the electric
signal induced by the tag MNPs on the target of interest is detected by the buried CMOS signal
extraction front-end circuit and conveyed off-chip (or to the on-chip ASIC) for signal process‐
ing by the back-end circuits. Since the chemical bonding and hybridization between the probe
and target are specific, multiple target detections from one sample droplet can, therefore, be
realized in parallel on the single biochip. This increases the detection efficiency and reduces
the cost. Depending on the non-specific bonding rate between the different probes and targets,
the number of targets supported by a single detection has to be traded with the fake positive
rate and detection sensitivity.
CMOS Chip
(a) (b)
Detection 
Region 2
 Detection 
Region 1
Target 
Detection Probe Molecules 
Target Molecule
MNP
(c)(d)
Rinse
Detection 
Region 3
Probe Molecule 
Immobilization
Probe 2 Probe 1 Probe 3
Signal 
Extraction and 
Evaluation
Figure 10. Oscillator-based high sensitivity multi-target biochip detection sketch.
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4.2. Design challenges and considerations
4.2.1. Sensor design
4.2.1.1. Running frequency
The free running frequency f0 of the oscillator has to be optimized, based on the consider‐
ations of phase noise, inductor detection region geometry and the response frequency of
MNPs. Most MNPs with a diameter of 500 nm or below exhibit a response frequency of
lower than 1.5 GHz [24], defining the upper boundary of f0. Although a low f0 would present
a lower phase noise, other factors include increasing the number of turns of the inductor
itself, shrinking the effective detection region size and degrading the uniformity of magnetic
field on the surface. Among the above factors, experiments suggest an f0 of around 1 GHz
- 1.5 GHz, with a proper trade-off.
4.2.1.2. Q of the inductor
The quality factor (Q) of the inductor also has to be optimized, considering the sensor dimen‐
sion and phase noise of the LO oscillator, which directly correlate to the sensitivity of the
biochip. Sensor dimensions are normally established from the chip size, multi-target capabil‐
ities and microfluidic channel structures, etc. For a given sensor size, the Q of the inductor can
be improved by optimizing the number of metal layers, turns, trace width and spacing of the
traces. For example, in a standard 180 nm CMOS process, the Q of the inductor can be
maximized as 5.2 by paralleling the top three to four layers of metals with a reasonable
inductance of 1.7 nH in a chip area of 130 µm x 130 µm. This is a fairly desirable value in the
design, as shown in Figure 11.
Figure 11. Q and inductance of an optimized inductor versus metal layers.
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4.2.1.3. Uniformity of the magnetic field
Uniformity of the surface magnetic field becomes important when the sensitivity is pushed
aggressively to an extremely low level or even for single molecule/MNP detection applications.
In this case, it has to be co-optimized with Q and the inductance of the inductor itself. Bowl-
shape [16] and multi-layer structured [25] round shape inductor sensors are investigated to
improve the field uniformity. However, the Q of the inductor of interest is substantially
degraded. A non-uniform inductor trace width strategy has been investigated to improve the
field uniformity. For example, as the trace width of the inner winding has been adjusted to 9
µm, as opposed to a width of 8 µm, for the rest of the outer windings in a three turn inductor,
the field uniformity can be decently improved, as shown in Figure 12. It can be seen that the
magnetic field intensity varies by roughly 20 % over the inductor surface before optimization.
With the proposed technique, it is reduced to about 5 %.
Figure 12. Simulated magnetic field uniformity on the optimized inductor surface.
4.2.2. Biochip design
The block diagram of a CMOS high sensitivity oscillator-based biochip is shown in Figure 13.
On different detection regions in a microarray, the output oscillation signal from the LC
oscillators is firstly processed by a multiplexer for selection. It is then down-converted to an
intermediate frequency (IF) and subsequently extracted by a low noise band-pass filter (BPF)
for out-of-band noise and spur suppression. The frequency synthesizer and circuitry supply
can be realized either on-chip or off-chip, depending on the applications. The IF signal is further
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digitized by an ADC off-chip, as shown in Figure 14. FFT is applied on the digitized IF signal
to calculate the frequency shift induced by the attached MNPs and eventually, obtain the
standard curve for biodetection and evaluation purposes. The ADC, FFT and following
calculation can be verified through off-chip and commercial chips/FPGA/Matlab. It is then
considered to be realized on-chip for a system-on-a-chip (SoC) solution.
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Figure 13. Circuit schematic of the oscillator-based biochip.
The challenging parts from the front-end biochip and back-end circuits are from the following
aspects.
CMOS Biochip
Analog to Digital 
Converter
Fast Fourier 
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Frequency Shift 
Evaluation and 
Voltage, Temperature 
Calibrations
Sensitivity 
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Curve
Off-chip verification
Figure 14. Block diagram of a CMOS high sensitivity oscillator-based biochip front-end and signal processing back-
end.
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4.2.2.1. Architecture of the signal down-conversion chain
The down-conversion chain of the proposed oscillator-based biochip is similar to that of the
conventional RF front-end circuits for wireless communication, including direct conversion
and heterodyne architectures. Since the output from a detection unit is a large signal with high
output swing and considering the injection pulling effects, the LO signal from the frequency
synthesizer should be at a different frequency from the unit. On the other hand, since the
frequency of interest is around 1 GHz - 1.5 GHz, a double conversion is less efficient, owing
to the power hungry dividers, buffers, etc. Therefore, a low IF architecture is preferred,
considering the trade-off among architectures, complexity and power.
4.2.2.2. Optimization of LO frequency
Being different from conventional receivers, there are no imaging effects in the proposed
biochip. Unfortunately, the selection of LO should be traded with the dynamic range and
sensitivity. A high LO would induce a reduction in the dynamic range and sensitivity, while
an over-low LO frequency would increase the IF frequency, burdening the design of BPF and
increasing power. The LO frequency has to be optimized based on the considerations of
sensitivity, dynamic range and power.
As shown in Figure 14, FFT is applied on the digitized IF signal from the ADC in order to
calculate the frequency shift induced by the attached MNPs and eventually, obtain the
standard curve for biodetection and evaluation purposes.
In this part, we need to apply a Hanning window on the signal to suppress the spectrum
leakage of FFT, before translating it into frequency domain. This improves the spectrum
uniformity and sensitivity.
4.2.3. Calibrations
Frequency drifting is a major issue for oscillator-based microarray biochips. Conventional
assays introduce an additional LC tank for reference in order to cancel out the common-
mode noises including drifts and PVT variations, however, increasing the chip area due to
the large footprint of the on-chip inductor [24]. In this section, an "in-situ switched capacitor
(ISSC) based calibration" scheme is presented by introducing only one switched capacitor
in the LC tank for common-mode noise rejection, as shown in Figure 15. An enabling switch
is used for the state switching and the measured frequencies between the adjacent time
cycles  are  subtracted  for  the  cancellation  of  common-mode  voltage  and  temperature
variations. The obtained frequency offsets in the initial state foffset and after introducing the
MNPs f’offset follow that:
offset offset
Lf f L0
1 2
æ öD¢ = -ç ÷ç ÷è ø
(12)
Biosensors - Micro and Nanoscale Applications128
Then, we have:
offset
offset
f fL M
L f f L0 0 0
12 2
a¢ DD = - = = (13)
Since all of the frequency drifting relating to the voltage and temperature variations are
common-mode and cancelled out, the output signal, which is proportional to the MNP density
within the inductor detection region, can therefore be obtained from the above relation.
The switching time has to be optimized, considering the typical voltage and temperature
variation rates for the best cancellation. In this prototype, an empirical value of 0.1 s is found.
In comparison to conventional dual-site cancellation scheme, this method is advantageous in
terms of both circuit complexity and cost areas, supporting more detection regions on a single
chip. It is capable of swiping out both drifts and PVT variation and does not require compli‐
cated external processing. Therefore, it improves the sensitivity and reliability of the multi-
target detection, as well as simplifying the implementation.
Figure 15. ISSC differential reference scheme for the voltage and temperature calibrations.
Silicon-based Integrated Microarray Biochips for Biosensing and Biodetection Applications
http://dx.doi.org/10.5772/60441
129
4.2.4. Experimental results and discussions
An oscillator-based microarray biochip prototype has been designed and fabricated in the
standard 180 nm CMOS process. The die micrograph is shown in Figure 16(a). The chip is
designed with two inductor detection regions, which are 130 µm in diameter. The measured
results show that the oscillator works properly at a centre frequency of 1.45 GHz, with a phase
noise of -120 dBc/Hz at 1 MHz offset and an output swing of larger than 1.25 V, while
consuming 55 mW of power.
In the experiment, a standard 500 nm MNP sample solution has been utilized for verification
and evaluation of the oscillator-based microarray biochip. The microscope picture of the
distributed MNPs on the inductor detection region of the biochip is shown in Figure 16(b). The
sample solution has been diluted by 50, 500, 5000 and 50000 times, respectively. The measured
output frequency offset versus the dilution ratio is shown in Figure 17.
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Figure 16. (a): Die micrograph of the oscillator-based microarray prototype and (b) the distributed MNPs on the induc‐
tor detection region of the oscillator-based microarray biochip.
It is found that the oscillator-based biochip works properly and a frequency shifting sensitivity
of about 17 kHz has been achieved, roughly corresponding to about 10 ppm. The proposed
ISSC calibration scheme is further applied and characterized through experiment. The output
frequency shifts corresponding to different numbers of MNPs on the detection region are
measured as shown in Figure 18, in which the exact quantity of MNPs is obtained from
scanning electron microscope (SEM) images. The effective noise floor (defined as the standard
deviation of measured frequency shift) of the sensor after ISSC calibration is 896 Hz, corre‐
sponding to about 0.62 ppm, and the extrapolated frequency shift for one single 500 nm MNP
is 138.5 Hz which is related to the size and material of the MNPs, running frequency, and
inductor structure. The maximal frequency shift is measured as 9.2 MHz, implying a dynamic
range of at least 80.2 dB, while the area of the sensor detection region is only 60000 µm2, well
below other calibration schemes. The comparisons with prior arts are shown in Table 2.
Compared with the electrochemical, GMR and MTJ biosensing strategies, the oscillator-based
microarray biochip potentially features high sensitivity, good compatibility with CMOS
technology, low cost, and multi-target capabilities.
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Figure 17. The measured output frequency offset versus the dilution ratio.
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Figure 18. Frequency shifts corresponding to different numbers of MNPs.
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ISSC scheme
This work Differential scheme [17]
CDC scheme
[17]
Operation freq. f 0 1.44 GHz 1.13 GHz 1.13 GHz
Phase noise at 1MHz -123.4 dBc/Hz -120.3 dBc/Hz -120.3 dBc/Hz
Dynamic range 80.2 dB 85.4 dB 85.4 dB
Effective noise floor/
operation freq. 0.62 ppm 1.07 ppm 0.35 ppm
On-chip area per sensing
region 60000 µm
2 >72000 µm2 72000 µm2
Technology 0.18-µm CMOS 45-nm SOI CMOS 45-nm SOI CMOS
Table 2. Comparisons with state-of-the-art oscillator-based biochips with calibrations.
5. Conclusions and future directions of IMB
Silicon-based IMBs with high sensitivity and multi-target capabilities have caught the attention
of both industry and academia for future accurate and early disease diagnosis and treatment.
Compared with conventional assays, such as ELISA and fluorescent detections, CMOS IMBs
are advantageous in various aspects. Such advantages include low cost, large-scale, readily
integration with signal extraction and processing front-end and back-end circuits monolithi‐
cally for a lab-on-a-chip solution, etc. In this chapter, state-of-the-art silicon-based IMB assays,
including electrochemical microarray biochips, GMR and MTJ microarray biochips and fully
CMOS compatible oscillator microarray biochips, are reviewed and discussed. Multiple
challenges and issues, as well as novel techniques in the research and production of silicon-
based IMB, are also presented.
In summary, silicon-based IMB provides fertile ground for future innovations. More specifi‐
cally, electrochemical microarray biochips are one type of widely interested assay, which are
capable of mid-sensitivity multi-target detection. In future research, various issues need to be
solved such as background noise and random currents in a biochemical sample solution
medium during the shrinking of electrode feature size, post-CMOS fabrication technologies
and parallel back-end signal processing and mode recognition. MTJ and GMR microarrays
assays are proved with extremely high sensitivities and provide full support to multi-target
(~100 targets) biochemical analysis applications. However, both biochips require extra
fabrication flow beyond the CMOS process, preventing the monolithic integration with
acquisition IC front-end, signal processing back-end and DSP for a SoC solution in order to
further improve system performance and reduce costs. Efforts have to be made to fix the
process compatibility issues. This can be achieved through chip-level integration and system-
in-a-package (SiP) solutions, etc. The oscillator-based microarray biochip features high
sensitivity, wide dynamic range, multi-target capabilities and full compatibility with CMOS
technology. Thus, it is potentially a suitable candidate for future SoC solutions. Calibration
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techniques for phase noise of LC oscillators and frequency drifting due to PVT variations
remains challenging and requires further innovations.
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